foxo4-dri peptide senolytic animal model 2023 UK | Research FOXO4 - an overview |
FOXO4 an overview ScienceDirect Topics The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. TWO NEW ADVANCED PEPTIDES JUST DROPPED at Luvion Bio The peptide world is evolving FAST and these two are already creating major buzz in longevity + immune research circles. FOXO4 DRI Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine
Pay in 4 interest-free payments of $6.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

